Anika Therapeutics ANIK
NASDAQ ANIK
$13.90 +0.43 (+3.19%)
As of: Nov 11, 2026 · 2:43 PM EST

Anika Therapeutics (ANIK) Liabilities from Discontinued Operations (2023 - 2024)

Updated

Anika Therapeutics' Liabilities from Discontinued Operations was $659,000 in Q4 2024, down 33.4% from $989,000 a year earlier.

Analysis

Anika Therapeutics (ANIK) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

  • In earlier years, Liabilities from Discontinued Operations was $989,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Anika Therapeutics 180.43 Mn -104.21 Mn 18.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 659,000.00
Dec 31, 2023 989,000.00
API Access

Anika Therapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=ANIK&period=max&api_key=YOUR_API_KEY